Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44027609HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44003530HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44027610HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44023964HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44004519HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44004693HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TCGA Plot Options
Drug Information
GeneNFATC1
DrugBank IDDB00852
Drug NamePseudoephedrine
Target IDBE0004878
UniProt IDO95644
Regulation Typeinhibitor
PubMed IDs21631396
CitationsFiebich BL, Collado JA, Stratz C, Valina C, Hochholzer W, Munoz E, Bellido LM: Pseudoephedrine inhibits T-cell activation by targeting NF-kappaB, NFAT and AP-1 signaling pathways. Immunopharmacol Immunotoxicol. 2012 Feb;34(1):98-106. doi: 10.3109/08923973.2011.582118. Epub 2011 Jun 2.
GroupsApproved
Direct ClassificationPhenylpropanes
SMILESCN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pathways
PharmGKBPA451170
ChEMBLCHEMBL1590